Litcius/Paper detail

Severe COVID-19 in an APS1 patient with interferon autoantibodies treated with plasmapheresis

Andri Leó Lemarquis, Tessa M. Campbell, Maribel Aranda‐Guillén, Viktoria Hennings, Petter Brodin, Olle Kämpe, Kaj Blennow, Henrik Zetterberg, Christine Wennerås, Kristina Eriksson, Nils Landegren, Yenan T. Bryceson, Stefan Berg, Olov Ekwall

2021Journal of Allergy and Clinical Immunology65 citationsDOIOpen Access PDF

Topics & Concepts

PlasmapheresisAutoantibodyMedicineCoronavirus disease 2019 (COVID-19)VirologyPandemic2019-20 coronavirus outbreakImmunologyInternal medicineAntibodyDiseaseOutbreakInfectious disease (medical specialty)Immunodeficiency and Autoimmune DisordersSystemic Lupus Erythematosus ResearchBlood disorders and treatments
Severe COVID-19 in an APS1 patient with interferon autoantibodies treated with plasmapheresis | Litcius